TY - JOUR AU - Bernard, G. R. AU - Vincent, J. L. AU - Laterre, P. F. AU - LaRosa, S. P. AU - Dhainaut, J. F. AU - Lopez-Rodriguez, A. AU - Steingrub, J. S. AU - Garber, G. E. AU - Helterbrand, J. D. AU - Ely, E. W. AU - Fisher, C. J. PY - 2001 DA - 2001// TI - Efficacy and safety of recombinant human activated protein C for severe sepsis JO - N Engl J Med VL - 344 UR - https://doi.org/10.1056/NEJM200103083441001 DO - 10.1056/NEJM200103083441001 ID - Bernard2001 ER - TY - STD TI - US Food and Drug Administration: Drotrecogin alfa (activated), Xigris, BLA #125029/0. FDA Briefing Information.US Food and Drug Administration 6 August 2001 [http://www.fda.gov/cber/label/droteli112101LB.pdf] UR - http://www.fda.gov/cber/label/droteli112101LB.pdf ID - ref2 ER - TY - STD TI - US Food and Drug Administration: Drotrecogin alfa (activated), Xigris, BLA #125029/0. FDA Briefing Information.US Food and Drug Administration [http://www.fda.gov/cber/label/droteli112101r1.pdf] UR - http://www.fda.gov/cber/label/droteli112101r1.pdf ID - ref3 ER - TY - JOUR AU - Knaus, W. A. AU - Draper, E. A. AU - Wagner, D. P. AU - Zimmerman, J. E. PY - 1985 DA - 1985// TI - APACHE II: a severity of disease classification system JO - Crit Care Med VL - 13 UR - https://doi.org/10.1097/00003246-198510000-00009 DO - 10.1097/00003246-198510000-00009 ID - Knaus1985 ER - TY - STD TI - European Agency for the Evaluation of Medicinal Products (EMEA): European Public Assessment Report [EPAR] Xigris.European Agency for the Evaluation of Medicinal Products 17 Oct 2002 [http://www.eudra.org/humandocs/Humans/EPAR/xigris/xigris.htm] UR - http://www.eudra.org/humandocs/Humans/EPAR/xigris/xigris.htm ID - ref5 ER - TY - JOUR AU - Dhainaut, J. F. AU - Laterre, P. F. AU - Janes, J. M. AU - Bernard, G. R. AU - Artigas, A. AU - Bakker, J. AU - Riess, H. AU - Basson, B. R. AU - Charpentier, J. AU - Utterback, B. G. AU - Vincent, J. L. PY - 2003 DA - 2003// TI - Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial JO - Intens Care Med VL - 29 ID - Dhainaut2003 ER - TY - JOUR AU - Ely, E. W. AU - Laterre, P. F. AU - Angus, D. C. AU - Helterbrand, J. D. AU - Levy, H. AU - Dhainaut, J. F. AU - Vincent, J. L. AU - Macias, W. L. AU - Bernard, G. R. PY - 2003 DA - 2003// TI - Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis JO - Crit Care Med VL - 31 UR - https://doi.org/10.1097/00003246-200301000-00002 DO - 10.1097/00003246-200301000-00002 ID - Ely2003 ER - TY - JOUR AU - Esmon, C. T. PY - 1992 DA - 1992// TI - The protein C anticoagulation pathway JO - Arterioscler Thromb VL - 12 UR - https://doi.org/10.1161/01.ATV.12.2.135 DO - 10.1161/01.ATV.12.2.135 ID - Esmon1992 ER - TY - JOUR AU - Riewald, M. AU - Petrovan, R. J. AU - Donner, A. AU - Mueller, B. M. AU - Ruf, W. PY - 2002 DA - 2002// TI - Activation of endothelial cell protease activated receptor 1 by the protein C pathway JO - Science VL - 296 UR - https://doi.org/10.1126/science.1071699 DO - 10.1126/science.1071699 ID - Riewald2002 ER - TY - JOUR AU - Joyce, D. E. AU - Gelbert, L. AU - Ciaccia, A. AU - DeHoff, B. AU - Grinnell, B. W. PY - 2001 DA - 2001// TI - Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.C100017200 DO - 10.1074/jbc.C100017200 ID - Joyce2001 ER - TY - JOUR AU - Schein, R. M. H. AU - Kinasewitz, G. T. PY - 2002 DA - 2002// TI - Risk-benefit analysis for drotrecogin alfa (activated) JO - Am J Surg VL - 184 UR - https://doi.org/10.1016/S0002-9610(02)01134-0 DO - 10.1016/S0002-9610(02)01134-0 ID - Schein2002 ER - TY - JOUR AU - Bernard, G. AU - Macias, W. L. AU - Joyce, D. E. AU - Williams, M. D. AU - Bailey, J. AU - Vincent, J. L. PY - 2003 DA - 2003// TI - Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis JO - Crit Care VL - 7 UR - https://doi.org/10.1186/cc2167 DO - 10.1186/cc2167 ID - Bernard2003 ER - TY - JOUR AU - Oppenheim-Eden, A. AU - Glantz, L. AU - Eidelman, L. A. AU - Sprung, C. L. PY - 1999 DA - 1999// TI - Spontaneous intracerebral hemorrhage in critically ill patients: incidence over six years and associated factors JO - Intens Care Med VL - 25 UR - https://doi.org/10.1007/s001340050788 DO - 10.1007/s001340050788 ID - Oppenheim-Eden1999 ER - TY - JOUR AU - Warren, B. L. AU - Eid, A. AU - Singer, P. AU - Pillay, S. S. AU - Carl, P. AU - Novak, I. AU - Chalupa, P. AU - Atherstone, A. AU - Penzes, I. AU - Kubler, A. AU - Knaub, S. AU - Keinecke, H. O. AU - Heinrichs, H. AU - Schindel, F. AU - Juers, M. AU - Bone, R. C. AU - Opal, S. M. PY - 2001 DA - 2001// TI - Caring for the critically ill patient: high-dose antithrombin III in severe sepsis:a randomized controlled trial JO - JAMA VL - 286 UR - https://doi.org/10.1001/jama.286.15.1869 DO - 10.1001/jama.286.15.1869 ID - Warren2001 ER - TY - JOUR AU - Heiro, M. AU - Nikoskelainen, J. AU - Engblom, E. AU - Kotilainen, E. AU - Marttila, R. AU - Kotilainen, P. PY - 2000 DA - 2000// TI - Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland JO - Arch Intern Med VL - 160 UR - https://doi.org/10.1001/archinte.160.18.2781 DO - 10.1001/archinte.160.18.2781 ID - Heiro2000 ER - TY - JOUR AU - Cabell, C. H. AU - Pond, K. K. AU - Peterson, G. E. AU - Durack, D. T. AU - Corey, G. R. AU - Anderson, D. J. AU - Ryan, T. AU - Lukes, A. S. AU - Sexton, D. J. PY - 2001 DA - 2001// TI - The risk of stroke and death in patients with aortic and mitral valve endocarditis JO - Am Heart J VL - 142 UR - https://doi.org/10.1067/mhj.2001.115790 DO - 10.1067/mhj.2001.115790 ID - Cabell2001 ER - TY - JOUR AU - Macias, W. L. AU - Dhainaut, J. F. AU - Yan, S. C. AU - Helterbrand, J. D. AU - Seger, M. AU - Johnson, G. AU - Small, D. S. PY - 2002 DA - 2002// TI - Pharmacokinetic-pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis JO - Clin Pharmacol Ther VL - 72 UR - https://doi.org/10.1067/mcp.2002.128148 DO - 10.1067/mcp.2002.128148 ID - Macias2002 ER - TY - JOUR AU - Laterre, P. F. AU - Heiselman, D. PY - 2002 DA - 2002// TI - Management of patients with severe sepsis, treated by drotrecogin alfa (activated) JO - Am J Surg VL - 184 UR - https://doi.org/10.1016/S0002-9610(02)01135-2 DO - 10.1016/S0002-9610(02)01135-2 ID - Laterre2002 ER - TY - JOUR AU - Taylor, F. B. AU - Toh, C. H. AU - Hoots, W. K. AU - Wada, H. AU - Levi, M. PY - 2001 DA - 2001// TI - Towards definition, clinical and laboratory criteria, and scoring system for disseminated intravascular coagulation JO - Thromb Haemost VL - 86 ID - Taylor2001 ER -